Key Developments in the HER2 Testing Market 2023-2029


Posted August 24, 2024 by aishwaryammr

HER 2 Testing Market size was valued at USD 136.04 Mn in 2022 and is expected to reach USD 221.32 Mn by 2029, at a CAGR of 7.2 %.
 
HER 2 Testing Market Overview

Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER 2 Testing Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive landscape. The report provides the current state of the HER 2 Testing market by thorough analysis, and projections are made up to 2030.

𝐅𝐨𝐫 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲, 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/request-sample/188548/

HER 2 Testing Market Scope and Methodology:

The HER 2 Testing market report covers a wide range of topics that impact market dynamics, trends, opportunities, and challenges. It also includes a thorough analysis of the worldwide landscape. This comprehensive analysis also looks at how the market is divided into segments according to services category, company size, end-user sector, and geographical regions. The study also closely examines major industry participants, assessing their approaches, line of business, results, and place in the HER 2 Testing market. To give a comprehensive picture of the market environment, a thorough evaluation of macroeconomic variables, regulatory frameworks, and technical developments is also carried out.

The report concludes that there are significant opportunities in the market through a thorough examination of the situation of HER 2 Testing market mergers and acquisitions, R&D initiatives, new industrial processes, innovative forms of advancement, and buyer direct. The papers highlight the tactics, portfolios, organizational structures, and astute analysis of the top players in the HER 2 Testing industry. A thorough SWOT analysis & PESTLE evaluation were carried out to ascertain the trends in the HER 2 Testing market in order to identify market developments and open doors that effect the microeconomic elements that are available.

HER 2 Testing Market Regional Insights

Regional insights play a vital role in understanding the nuanced dynamics of the HER 2 Testing market. The HER 2 Testing market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The report offers a comprehensive examination of factors, market size, growth rate, and import and export activities within each region. The Regional Analysis section presents the current status of the HER 2 Testing market in the countries covered in the report.

HER 2 Testing Market Segmentation

by Product

1. Fluorescence in situ hybridization(FISH)
2. Immunohistochemistry (IHC)
3. Chromogenic in situ hybridization (CISH)
4. Silver-enhanced in situ hybridization


by Cancer Type

1. Breast Cancer
2. Gastric Cancer
3. Bladder cancer
4. Ovarian cancer


by End-Users

1. Hospitals
2. Diagnostic Laboratories
3. Specialty Clinics
4. Others

Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC), Chromogenic in situ hybridization (CISH), and Silver-enhanced in situ hybridization are the four market segments based on the technology. In 2022, the fluorescence in situ hybridization (FISH) segment had a dominant position in the market and is anticipated to have significant growth going forward. A molecular cytogenetic technique called fluorescence in situ hybridization (FISH) allows one to localize a specific DNA sequence or an entire chromosome within a cell. Moreover, it is employed in the identification of novel oncogenes, gene mapping, and the diagnosis of genetic diseases. When compared to other conventional techniques, the FISH approach requires less time to complete.

The most well-known and practical method for measuring the level of HER2/neu gene in individual cancer cells in breast cancer is the FISH test. The FISH method has a high turnaround time, precision, and accuracy due to its capacity to identify genetic aberrations in non-dividing and non-viable tissues.

The market is divided into four segments based on the kind of cancer: ovarian, bladder, gastric, and breast cancer. Over the course of the projection period, breast cancer is anticipated to have the greatest growth rate in the HER 2 testing market. The risk factors that raise the incidence of breast cancer include aging, genetic mutations, reproductive history, having thick breasts, having a personal or family history of the disease, and drug exposure. HER3 genes change and produce additional copies of themselves in breast cancer. The purpose of HER2 testing is to determine whether the cancer is HER-2 positive and to determine whether the malignancy is responding to treatment or coming back after it has been stopped.

The market is divided into Hospitals, Diagnostic Laboratories, Specialty Clinics, and Others based on the end users. In 2022, hospitals will hold the top spot in the industry and are predicted to develop rapidly. This test was primarily used by clinicians in hospitals to identify tumors with higher-than-normal amounts of the HER2 protein or cancer cells with an excessive number of HER2 gene copies. Hospital laboratories examine a sample of breast cancer tissue retrieved during surgery or biopsy for HER2 levels in invasive breast tumors. Rather than diagnostic labs, the hospitals are equipped with state-of-the-art medical technology. The Fluorescence in Situ Hybridization (FISH) apparatuses are readily accessible and a crucial prerequisite for the HER 2 examination.

𝐅𝐨𝐫 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲, 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/request-sample/188548/

HER 2 Testing Market Key Players

1. Abbot
2. Roche
3. Agilent Technologies,Inc.
4. Thermo Fisher Scientific Inc.
5. Empire Genomics Inc.(Bio care Medical LLC)
6. Abnova Corporation
7. Oxford Gene Technology IP limited
8. BCRF
9. Genetech
10. Genemed Technologies Inc.
11. PERKINELMER Inc.
12. QIAGEN
13. BioDot
14. BioGenex (U.S)

𝐅𝐨𝐫 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲, 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/request-sample/188548/

Key questions answered in the HER 2 Testing Market are:

What is HER 2 Testing?
What was the HER 2 Testing market size in 2023?
Who are the leading companies and what are their portfolios in HER 2 Testing Market?
What growth strategies are the players considering to increase their presence in HER 2 Testing?
What are the upcoming industry applications and trends for the HER 2 Testing Market?
Which are the factors expected to drive the HER 2 Testing market growth?
What are the recent industry trends that can be implemented to generate additional revenue streams for the HER 2 Testing Market?
What are the different segments of the HER 2 Testing Market?
What will be the CAGR at which the HER 2 Testing market will grow?
What is the growth rate of the HER 2 Testing Market?
What segments are covered in the HER 2 Testing Market?
What are the key challenges and opportunities in the HER 2 Testing market?
Which application holds the highest potential in the HER 2 Testing market?
Who are the key players in the HER 2 Testing market?
For further inquiries and market scope exploration, reach out to us: https://www.maximizemarketresearch.com/market-report/her-2-testing-market/188548/

Key Offerings:

Market Size, Share, Size & Forecast by different segment | 2024-2030
Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation – A detailed analysis by segment with their sub-segments and Region
Competitive Landscape – Profiles of selected key players by region from a strategic perspective
Competitive landscape – Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER’s analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
Recommendations
Related Reports: Global Dry Eye Disease Market https://www.maximizemarketresearch.com/market-report/dry-eye-disease-market/36619/
Global Automotive Onboard Charger Market https://www.maximizemarketresearch.com/market-report/global-automotive-onboard-charger-market/118813/

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected]

+91 96071 95908, +91 9607365656
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Aishwarya
Phone ✆ +91 9607365656
Business Address MAXIMIZE MARKET RESEARCH PVT. LTD.  3rd Floor, Navale IT park Phase 2,
 Pune Banglore Highway, Narhe  Pune, Maharashtra 411041, India.
Country India
Categories Health
Tags her 2 testing market , her 2 testing market business , her 2 testing market trends , her 2 testing market share
Last Updated August 24, 2024